Genomics: Clinical Implementation
This channel includes news headlines and educational resources regarding the clinical implementation of genomics assays, including development, validation, quality control, standardization, and the practical and commercial considerations for labs adopting these tests.
Personalis, Tempus Partner to Commercialize Blood-Based Minimal Residual Disease Test
Tempus will market Personalis' NeXT Personal Dx liquid biopsy assay while Personalis completes its clinical validation in more indications.
Germany to Test Genomics-Based Precision Medicine for Cancer, Rare Disease in National Pilot Project
Premium
With reimbursement from public health insurance, the "model project" will run for at least five years and examine the utility of genomic sequencing for advanced cancer and rare disease patients.
Cardio Diagnostics Publishes Validation Data for Molecular Coronary Heart Disease Test
The new study in the Journal of the American Heart Association shows that the firm's machine learning-based genetic-epigenetic approach can help diagnose coronary heart disease.
Verana Health, Foundation Fighting Blindness to Integrate Genetic Testing, Real-World Evidence
The partnership seeks to combine genomic data from the Foundation's My Retina Tracker Registry with patient-reported data from the IRIS Registry.
BostonGene, Exigent Research Ink Trial Agreement for Study of Comprehensive Cancer Sequencing
Using patient tumor samples from participating Exigent sites, BostonGene aims to validate its exome and RNA sequencing assay in a real-world setting.